Atherosclerosis is associated with plasminogen activator inhibitor type-1 in chronic haemodialysis patients

Nephrology

Volumn 13, Issue 7, 2008, Pages 579-586

  Peng, Youming ^a   Liu, Hong ^a   Liu, Fuyou ^a   Ouyang, Lin ^a   Cheng, Meichu ^a   Gao, Lei ^b   Pan, Fulin ^a   Liu, Yinghong ^a   Chen, Xing ^a   Li, Jun ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Atherosclerosis; Haemodialysis; Intima media thickness; Plaque score; Plasminogen activator inhibitor 1 (PAI 1)

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; CAROTID ARTERY; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; HEMODIALYSIS; HUMAN; HUMAN TISSUE; ILIAC ARTERY; IMMUNOHISTOCHEMISTRY; INTERNAL ILIAC ARTERY; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

ADULT; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; CHOLESTEROL, LDL; FEMALE; HUMANS; ILIAC ARTERY; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; RENAL DIALYSIS; RISK FACTORS;

EID: 54049101113     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2008.00987.x     Document Type: Article

References (31)

1. Ma KW, Greene EL, Raij L. Cardiovascular risk factors in chronic renal failure and hemodialysis populations. Am. J. Kidney Dis. 1992 19 : 505 13.
2. Cheung AK, Sarnak MJ, Yan G et al. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int. 2000 58 : 353 62.
3. Ross R. The pathogenesis of atherosclerosis - an update. N. Engl. J. Med. 1986 314 : 488 500.
4. Blann AD, Taberner DA. A reliable marker of endothelial cell dysfunction: Does it exist?. Br. J. Haematol. 1995 90 : 244 8.
5. Thogersen AM, Jansson JH, Boman K et al. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: Evidence for the fibrinolytic system as an independent primary risk factor. Circulation 1998 98 : 2241 7.
6. Bourcier T, Libby P. HMG CoA reductase inhibitors reduce plasminogen activator inhibitor-1 expression by human vascular smooth muscle and endothelial cells. Arterioscler. Thromb. Vasc. Biol. 2000 20 : 556 62.
7. Bots ML, Hoes AW, Hofman A et al. Cross-sectionally assessed carotid intima-media thickness relates to long-term risk of stroke, coronary heart disease and death as estimated by available risk functions. J. Intern. Med. 1999 245 : 269 76.
8. Chambless LE, Heiss G, Folsom AR et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: The Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am. J. Epidemiol. 1997 146 : 483 94.
9. Suwelack B, Witta J, Hausberg M et al. Studies on structural changes of the carotid arteries and the heart in asymptomatic renal transplant recipients. Nephrol. Dial. Transplant. 1999 14 : 160 65.
10. Shen H. Study of the quantitative method of immunohistochemistry(III). J. Chin. Histochem. Cytochem. 1995 4 : 89 91.
11. Vaughan DE. PAI-1 and atherothrombosis. J. Thromb. Haemost. 2005 3 : 1879 83.
12. Mussoni L, Baldasarre D, Mannucci L et al. Relationship between fibrinolytic variables: A study in patients attending a lipid clinic. Ann. Med. 2000 32 : 134 41.
13. Tomura S, Nakamura Y, Mayumi D et al. Fibrinogen, coagulation factor VII, tissue plasminogen activator, plasminogen activator inhibitor-1, and lipid as a cardiovascular risk factors in chronic hemodialysis and continuous ambulatory peritoneal dialysis. Am. J. Kidney Dis. 1996 27 : 848 54.
14. Banfi C, Mussoni L, Rise P et al. Very low density lipoprotein-mediated signal transduction and plasminogen activator inhibitor type-1 in cultured HepG2 cells. Circ. Res. 1999 85 : 208 17.
15. Attman PO, Alaupovic P. Lipid and apolipoprotein profiles of uremic dyslipoproteinemia - Relation to renal function and dialysis. Nephron 1991 57 : 401 10.
16. Padró T, Steins M, Li CX et al. Comparative analysis of plasminogen activator inhibitor-1 expression in different types of atherosclerotic lesions in coronary arteries from human heart explants. Cardiovasc. Res. 1997 36 : 28 36.
17. Juhan-Vague I, Pyke S, Alessi MC et al. Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. Circulation 1996 94 : 2057 63.
18. Hong HK, Cho YM, Park KH et al. Peroxisome proliferator-activated receptor gamma mediated inhibition of plasminogen activator inhibitor type 1 production and proliferation of human umbilical vein endothelial cells. Diabetes Res. Clin. Pract. 2003 62 : 1 8.
19. Wu-Wong JR, Nakane M. Vitamin D analogs down-regulate plasminogen activator inhibitor-1 in human coronary artery smooth muscle cells. J. Thromb. Haemost. 2005 3 : 1545 6.
20. Savage T, Clarke AL, Giles M et al. Calcified plaque is common in the carotid and femoral arteries of dialysis patients without clinical vascular disease. Nephrol. Dial. Transplant. 1998 13 : 2004 12.
21. Sander D, Kligelhofer J. Diurnal systolic blood pressure variability is the strongest predictor of early carotid atherosclerosis. Neurology 1996 47 : 500 7.
22. Drüeke T, Witko-Sarsat V, Massy Z et al. Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease. Circulation 2002 106 : 2212 17.
23. Papagianni A, Kalovoulos M, Kirmizis D et al. Carotid atherosclerosis is associated with inflammation and endothelial cell adhesion molecules in chronic haemodialysis patients. Nephrol. Dial. Transplant. 2003 18 : 113 9.
24. Okhuma T, Minagawa T, Takada N et al. C-reactive protein, lipoprotein (a), homocysteine, and male sex contribute to carotid atherosclerosis in peritoneal dialysis patients. Am. J. Kidney Dis. 2003 42 : 355 61.
25. Danesh J, Whincup P, Walker M et al. Low grade inflammation and coronary heart disease: Prospective study and updated meta-analyses. Br. Med. J. 2000 321 : 199 204.
26. Okhuma T, Minagawa T, Takada N et al. C-reactive protein, lipoprotein (a), homocysteine, and male sex contribute to carotid atherosclerosis in peritoneal dialysis patients. Am. J. Kidney Dis. 2003 42 : 355 61.
27. Zoccali C, Benedetto FA, Mallamaci F et al. Inflammation is associated with carotid atherosclerosis in dialysis patients. J Hypertens. 2000 18 : 1207 13.
28. Bologa RM, Levine DM, Parker ST et al. Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia and mortality in hemodialysis patients. Am. J. Kidney Dis. 1998 32 : 107 14.
29. Kario K, Matsuo T, Kobayashi H et al. High lipoprotein(a) levels in chronic hemodialysis patients are closely related to the acute phase reaction. Thromb. Haemost. 1995 74 : 1020 4.
30. Kaizu Y, Kimura M, Yoneyama T et al. Interleukin-6 mediate malnutrition in chronic hemodialysis patients. Am. J. Kidney Dis. 1998 31 : 93 100.
31. Stenvinkle P, Hleimburger O, Lindholm B et al. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation, and atherosclerosis(MIA syndrome). Nephrol. Dial. Transplant. 2000 15 : 953 60.